Brain

International Myeloma Foundation and the Black Swan Research Initiative Showcase Six Oral & Poster Abstracts by the iStopMM Project at the 2023 ASH Annual Meeting

iStopMM team members Thorir Einarsson Long, Jon Thorir Oskarsson, and Sæmundur Rognvaldsson are 2023 ASH Abstract Achievement AwardeesSTUDIO CITY, Calif.,…

12 months ago

Ability KC Selects Netsmart to Advance Technology Within Outpatient Medical Rehabilitation

This Collaboration Extends to Making a Positive Impact in the Community Through EveryDayMatters Foundation InitiativesOVERLAND PARK, Kan.--(BUSINESS WIRE)--#AbilityKC--Ability KC, a…

12 months ago

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

JACKSON CENTER, PA / ACCESSWIRE / January 11, 2024 / Halberd Corporation (OTC PINK:HALB) made significant advances in its technology…

12 months ago

Nexalin Technology Unveils Next-Generation HALO™ Clarity

HALO™ Clarity headset Photo: HALO™ Clarity headset A new neurostimulation device to combat the growing global mental health epidemic Designed…

12 months ago

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…

12 months ago

Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story

NORTHAMPTON, MA / ACCESSWIRE / January 10, 2024 / Gilead Sciences:When employees at Gilead's recently opened New Jersey office need…

1 year ago

CORRECTION BY SOURCE: Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Correction: The initial release stated Mr. Peter Croden was previously Global President of Upjohn/Pfizer Animal Health Division in Germany. The…

1 year ago

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

Initiation of REVEAL pediatric trial in the U.S. broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old…

1 year ago